Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27545815 | 0.88 | TSHR (0.41) | TSHRHPGDALDH1A1CTSK | |
| SCHEMBL111270 | 0.86 | FAAH (0.39) | TSHRGALR3ALDH1A1 | |
| SCHEMBL15645172 | 0.86 | FAAH (0.39) | TSHRGALR3ALDH1A1 | |
| SCHEMBL15689848 | 0.86 | FAAH (0.39) | TSHRGALR3ALDH1A1 | |
| SCHEMBL6503353 | 0.85 | FAAH (0.41) | TSHRMAPT | |
| SCHEMBL15689858 | 0.85 | FAAH (0.41) | TSHRMAPT | |
| SCHEMBL8152281 | 0.85 | FAAH (0.41) | TSHRMAPT | |
| SCHEMBL16177782 | 0.85 | FAAH (0.41) | TSHRMAPT | |
| SCHEMBL28416992 | 0.85 | FAAH (0.41) | TSHRMAPT | |
| SCHEMBL12314345 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| US-12350136-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | claimed |
| US-20220401275-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2022-12-22 | — | — | US | claimed |
| US-11458049-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2022-10-04 | — | — | US | claimed |
| EP-3509647-B1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2020-10-21 | — | — | EP | claimed |
| EP-3509647-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | The Procter and Gamble Company (US) | 2019-07-17 | — | — | EP | claimed |
| WO-2018048852-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-15 | — | — | WO | claimed |
| US-20180064588-A1 | Absorbent Articles Including Perfume and Cyclodextrins | THE PROCTER & GAMBLE COMPANY | 2018-03-08 | — | — | US | claimed |
| EP-0060365-B1 | PROCESS FOR PRODUCING GAMMA-VINYL-GAMMA BUTYROLACTONE | MONSANTO COMPANY (US) | 1985-08-07 | — | — | EP | claimed |
| US-20260102294-A1 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-16 | — | — | US | disclosed |
| US-12533269-B2 | Absorbent article comprising a fragrance and an odor control composition | THE PROCTER & GAMBLE COMPANY (US) | 2026-01-27 | — | — | US | disclosed |
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | disclosed |
| US-12350135-B2 | Absorbent article with odor control composition | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | disclosed |
| US-12350136-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | disclosed |
| US-20070157323-A1 | In vivo odorant receptor systems and their uses | YALE UNIVERSITY | 2007-07-05 | — | — | US | disclosed |
| EP-1781239-A2 | COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR | Patus Ltd (IL) | 2007-05-09 | — | — | EP | disclosed |
| US-20070065394-A1 | Compositions effective in altering the perception of malodor | PATUS LTD. (IL) | 2007-03-22 | — | — | US | disclosed |
| WO-2005046632-A9 | COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR | PATUS LTD (IL) | 2005-09-22 | — | — | WO | disclosed |
| WO-2005062780-A2 | IN VIVO ODORANT RECEPTOR SYSTEMS AND THEIR USES | YALE UNIVERSITY (US) | 2005-07-14 | — | — | WO | disclosed |
| WO-2005046632-A2 | COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR | PATUS LTD. (IL) | 2005-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12533269-B2 | Absorbent article comprising a fragrance and an odor control composition | CUTA, CFD, MBTD1 | TSHR 4503/4885CHRM1 964/4885TDP1 2588/4885 |
| US-20260102294-A1 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION | CUTA, SHBG, DSG1 | TSHR 4291/4885CHRM1 1182/4885TDP1 3090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.